Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 4,277

Document Document Title
WO/2024/038721A1
A regrowth material for alveolar bone and periodontal ligaments, and a method for manufacturing the regrowth material for alveolar bone and periodontal ligaments, said regrowth material including a crosslinked product of gelatin.  
WO/2024/029242A1
Disclosed is a linear peptide or cyclic peptide having an amino acid sequence represented by formula (1): XN-X5-X6-X7-X8-X9-X10-X11-X12-X13-X14-X15 (1), or a pharmacologically acceptable salt thereof. Binding this peptide to LRP1 makes i...  
WO/2024/020690A1
A device or method for affinity binding on an aluminum oxide surface. A biomolecule provides for immobilizing on the aluminum oxide surface. The biomolecule includes a histidine rich domain, a metal binding domain, or a metal binding moi...  
WO/2024/024518A1
The present disclosure provides an enzyme electrode, etc., in which an enzyme is immobilized via a more appropriate bond. The enzyme electrode of the present disclosure comprises an electrode and a modified protein having an amino acid s...  
WO/2024/024517A1
The present disclosure provides, inter alia, an enzyme electrode obtained by immobilizing an enzyme by using more appropriate binding. The enzyme electrode according to the present disclosure comprises an electrode and a modified protein...  
WO/2024/014426A1
The present invention addresses the problem of clarifying the true cause of interstitial pneumonia that is associated with myositis/dermatomyositis to thereby enable a more accurate diagnosis of the onset risk of interstitial pneumonia a...  
WO/2024/003213A1
The present invention provides a molecular probe functionalized element comprising a solid base element, a first layer comprising a linker A, a second layer comprising a peptide compound, a third layer comprising a linker B, and a fourth...  
WO/2024/000262A1
Provided are a probe specifically binding to CD138, a kit and a microfluidic chip comprising the probe, and a method for diagnosing diffuse large B-cell lymphoma in a subject by using the probe, the kit or the microfluidic chip. Also pro...  
WO/2023/247468A2
The present invention relates to isolation and separation of kappa light chain-containing proteins. More specifically it relates to a separation matrix comprising kappa light chain-binding ligands covalently coupled to a porous support, ...  
WO/2023/183628A9
Disclosed herein are conjugate agents comprising a targeting moiety, directly or indirectly conjugated with a payload moiety, compositions comprising the same as well as methods of making and using the same.  
WO/2023/204043A1
Provided is a technique that enables isolation using few steps. Provided by this technique is a method for isolating biological particles, the method including: an immobilization step for immobilizing a sample containing biological parti...  
WO/2023/196306A1
Disclosed are methods for producing matrix-encapsulated proteins, including matrix-encapsulated hemoglobin. Also provided are pharmaceutical compositions comprising a matrix-encapsulated hemoglobin, as well as methods of using thereof to...  
WO/2023/181025A1
Provided herein are silica nanoparticles conjugated to a phosphate binding hexapeptide (PBH) via a linker amino acid residue and methods of making the same. Further provided are compositions including the nanoparticles and uses thereof i...  
WO/2023/180502A1
The present invention provides a compound for the sequestration of undesirable neutralizing antibodies against oncolytic viruses in a patient. The compound comprises an inert biopolymer scaffold and at least a first peptide n-mer of the ...  
WO/2023/170118A1
The present application discloses methods for characterising vesicles. The method involves (1) a sample preparation step, comprising providing a test specimen with vesicles attached to a substrate, wherein the vesicles are labelled with ...  
WO/2023/170216A1
A method for predicting the efficacy of an antibody drug conjugate (ADC) therapy involves determining the mean optical density (OD) of membrane and optionally cytoplasm staining of each cancer cell in a whole slide image. A diagnostic an...  
WO/2023/165529A1
Provided are a method for detecting migrasomes and a system. Provided is a method for detecting migrasomes, which comprises: (a) providing a sample to be tested; (b) mixing the sample to be tested with a solid-phase support to form a "mi...  
WO/2023/162903A1
The present invention addresses the problem of providing: a liquid that contains a group of exosome-like particles obtained by causing an arbitrarily defined membrane protein to be associated with lipid particles in which the particle si...  
WO/2023/157460A1
The present invention addresses the problem of specifying a factor involved in depression and aging and providing a method for the use thereof. This problem is solved by a method for acquisition of data for diagnosis or testing of SFPQ-r...  
WO/2023/142999A1
A nano vaccine used for delivering an mRNA antigen and derived from a bacterial outermembrane vesicle and the use thereof. Specifically provided is a technology for displaying nucleic acid on the outer surface of a vesicle.  
WO/2023/140197A1
The present invention addresses the problem of providing an improved adeno-associated virus (AAV)-binding protein having an enhanced binding ability to an AAV and a method for analyzing an AAV contained in a sample on the basis of differ...  
WO/2023/124207A1
The present application relates to the technical field of immunoglobulin separation and purification, and in particular, to an immunoglobulin-binding protein and an application thereof. The immunoglobulin-binding protein is obtained by s...  
WO/2023/127780A1
Provided is a cell culture scaffold material capable of maintaining cell culture stability over a long period. The cell culture scaffold material according to the present invention comprises a peptide-containing (meth)acrylic copolymer...  
WO/2023/127777A1
Provided is a scaffold material for cell culture with which it is possible to maintain the culture stability of cells over an extended period of time. A scaffold material for cell culture according to the present invention includes a p...  
WO/2023/127778A1
Provided is a scaffold material for cell culture, with which cell culture stability can be maintained over a long period of time. This scaffold material for cell culture contains a peptide-containing (meth)acrylic copolymer having: a (...  
WO/2023/127779A1
Provided is a coating solution for forming a cell scaffold that can easily form a thick cell scaffold and increase cell proliferation. This coating solution for forming a cell scaffold, according to the present invention, includes an a...  
WO/2023/122327A2
The present disclosure relates to the field of chromatography, and more specifically to novel affinity ligands and affinity agents which are suitable for use in isolation of antibody and antibody fragments that contain the heavy chain fi...  
WO/2023/106379A1
Provided are: cellulose porous particles which have large surface areas on which cells can be attached, and on which cells can be adhered easily, and which rarely undergo the detachment of cells when the cells are cultured at a high dens...  
WO/2023/100976A1
Disclosed is a peptide-immobilized bead library which, in comparison to well-known OPOB libraries, has a higher potential for an obtained peptide to become a useful substance candidate for a drug or the like, and makes it easier to analy...  
WO/2023/100974A1
The problem to be solved by the present invention is to provide a method which makes it possible to culture anchorage-dependent cells with a serum-free culture medium. The present invention provides a cell culture method including a step...  
WO/2023/095665A1
This antibody isolation method comprises: a step for adding a solution containing antibodies to a column filled with an antibody adsorption material containing an insoluble porous carrier and an Fc-binding protein immobilized on the carr...  
WO/2023/081924A1
Described in several embodiments herein are olfactory sensory neuron (OSN) derived extracellular vehicles (EVs), formulations thereof, and uses thereof. In some embodiments, the OSN derived extracellular vesicles are effective to increas...  
WO/2023/074642A1
[Problem] To provide a immunoglobulin-binding protein which has improved chemical stability, particularly stability with respect to alkalis, an immunoglobulin-binding protein which enables antibody elution in mild pH conditions, and an a...  
WO/2023/054636A1
The present invention relates to a compound having: (i) a photocleavable site; and (ii) at least one selected from the group consisting of a target substance binding site and an anchor binding site.  
WO/2023/032886A1
Provided are antibodies for use in an immunological measurement method, the antibodies including an Fc region and being such that at least some of the sugar chains included in the Fc region are removed.  
WO/2023/023869A1
Steroid acid-based hydrogels and methods of production thereof are described herein. More specifically, the present description relates to steroid acid-peptide conjugates for the formation of a hydrogel. Peptides are covalently conjugate...  
WO/2023/027082A1
The present invention addresses the problem of providing a hybrid liposome exosome or the like capable of delivering an active ingredient to a target cell at a higher concentration. This peptide-bound hybrid liposome exosome, which inc...  
WO/2023/026843A1
The present invention addresses the problem of providing a truly practical chemical sensor that is capable of highly sensitively detecting a target substance, such as an odorant, in a gas phase. The present inventors found that the afore...  
WO/2023/023889A1
A method for preparing amphiphiles with dendrimeric skeletons by a solid phase linker approach.  
WO/2023/027083A1
Provided are a method for detecting a gene mutation using an FFPE tissue section containing tumor cells regardless of the percentage of tumor cells, the method being capable of increasing the number of detectable gene mutations and mutan...  
WO/2023/015298A1
Methods of isolating a therapeutic protein from a sample are described herein. Kits for isolating a therapeutic protein from a sample are described herein.  
WO/2023/013618A1
The present invention addresses the problem of providing a way of identifying human astrovirus (HAstV) receptor molecules and developing an HAstV infection control means. The inventors have found that an FCGRT receptor protein and a B2M ...  
WO/2023/002944A1
[Problem] The present invention addresses the problem of providing a novel antibody that can prevent and/or treat SARS or COVID-19 infection. Provided is an antibody which comprises heavy-chain CDR1 comprising the amino acid sequence r...  
WO/2023/004273A1
The disclosure is directed to systems and methods for purifying proteins containing an Fc region, such as antibodies or Fc fusion proteins. The system includes one or more filler molecules comprising a linear hydrocarbon chain conjugated...  
WO/2023/277122A1
The purpose of the present invention is to provide a technique for detecting or separating polysialic acid or a polysialic acid-carrying body. Provided is at least one antibody selected from the group consisting of antibodies A to E.  
WO/2022/270482A1
The present invention provides: sugar chain immobilized polymer particles in which a hydrophobized sugar chain polypeptide is firmly immobilized to the outermost surface of the polymer particles and the sugar chain density on the surface...  
WO/2022/259719A1
The present invention addresses the problem of providing a means of detecting infection with Treponema pallidum bacterium at a higher sensitivity. The present inventor found that, in the measurement of anti-T. pallidum antibody in a body...  
WO/2022/243636A1
The present invention relates to a microfluidic chip capable of attracting and trapping a specific biological element, the chip comprising: - a reservoir (1) formed of a matrix comprising a chemoattractant compound capable of attracting ...  
WO/2022/239704A1
The present invention addresses the problem of providing a method for eliminating a glycosylation isomer from an antibody drug, etc. The present invention provides, for example, a purification method of an antibody composition, said puri...  
WO/2022/239810A1
Provided is a method for producing a dry microcarrier for cell cultivation, the method comprising: a step of immersing, using a solvent including gelatin, an alginic acid fine particulate gel including a cation having a valency of two or...  

Matches 1 - 50 out of 4,277